Learn more about how ObvioGo® accelerates clinical trials.
Collaboration adds critical decentralized trial capabilities to the Oracle Life Sciences Clinical One Data Collection solution
Issue 1: ObvioGo's new built-in eSignature, the Template Library and Out-of-Window Data Submissions features, caregiver-centric eDiary design, and how MiHelper accelerated a decentralized migraine study.
Discover how simplifying vaccine logistics can make scientific breakthroughs truly global — and why digital innovation is the missing link in equitable access.
Breaking down barriers in vaccine research: ObvioHealth and Vaxxas team up to advance needle-free vaccine innovation.
SPRIM PRO and ObvioHealth align science and technology to power decentralized and hybrid trial innovation.
As the FDA and HHS initiate a strategic review of the infant formula industry through Operation StorkSpeed, ObvioHealth’s experience in modernizing infant nutrition research offers a timely and relevant model for faster, safer, and more scalable clinical trials.
In response to rising healthcare demands, ObvioHealth is redefining clinical trials through decentralized models and patient-first technology that improves access, engagement, and data quality.